Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
LYELL IMMUNOPHARMA INC
Ticker: LYEL
CUSIP: 55083R203
Class: Common Stock
ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)
Note: Option positions (PUT/CALL) are excluded.
Q3 2025
Shares
51,727
Value ($000)
$840
Avg Close
$11.42
Range
$8.87 - $16.25
Q2 2025
Shares
51,727
Value ($000)
$457
Avg Close
$9.11
Range
$7.65 - $13.80
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2025
51,727
$840
$11.42
$8.87 - $16.25
Q2 2025
51,727
$457
$9.11
$7.65 - $13.80